Exploring the current use and future of alternatives to traditional informed consent in acute stroke trials
MSN highlights editorial authored by UC experts
MSN highlighted an editorial written by the University of Cincinnati’s Yasmin Aziz, MD, and Joseph Broderick, MD, published Nov. 7 in the journal Neurology analyzing the current use and potential future of alternatives to traditional informed consent in acute stroke trials.
Patient informed consent is a crucial part of ethical clinical trial design and implementation, but time is of the essence for stroke trials. Approximately 2 million neurons die each minute they are deprived of oxygen, and patients are also sometimes incapacitated and therefore unable to consent to a trial, highlighting the need for emergency consent in certain cases.
There is currently no worldwide standard for emergency consent for stroke trials, with various approaches taken by different countries.
“This editorial is intended to educate the greater neurology community about these consent procedures and their current relevance to stroke research in particular,” said Aziz, assistant professor in the Department of Neurology and Rehabilitation Medicine in UC’s College of Medicine and a UC Health physician.
Broderick is principal investigator of the FASTEST trial, the first acute stroke trial in the United States to use exception from informed consent (EFIC) protocols.
“...Community consultation and public disclosure are unique to EFIC,” the authors wrote. “Both requirements can be quite expensive and time-consuming, delaying study start-up. Efforts to make EFIC more efficient and less costly in the US are ongoing.”
The coauthors noted as the field continues to explore the most effective and efficient alternatives to prospective informed consent, the “principles of patient autonomy and beneficence remain imperative.” Aziz said improving consent procedures is an opportunity to “keep moving the chains forward” for stroke research.
“The United States in particular has a very dark, very recent, unethical history with certain populations and the performance of clinical research,” she said. “We need to find the best way to honor patient autonomy while moving research forward to ultimately get better treatments to the bedside.”
Neuro Rehab Times also covered the editorial. Read the Neuro Rehab Times article.
Featured photo at top of brain scans. Photo courtesy of Joseph Broderick.
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Position-specific helmets may not improve protection
March 16, 2026
Local 12 highlighted a new study by biomedical engineering researchers that looked at how well new football helmets protected players from impacts that can cause concussions.
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.